IP Library › Granted Patent US 7,312,314
Granted Patent B2
US 7,312,314 · App. 10/131,820 · Granted Dec 25, 2007

Antibody that binds a pro1693 polypeptide

Assignee: Genentech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,312,314
App. No.
10/131,820
Granted
Dec 25, 2007
Kind
B2
Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims (5)

1. An isolated antibody that specifically binds to the polypeptide of SEQ ID NO:536.

2. The antibody of claim 1 which is a monoclonal antibody.

3. The antibody of claim 1 which is a humanized antibody.

4. An antigen-binding fragment of the antibody of claim 1 .

5. The antibody of claim 1 which is labeled.

Continuity (7)
Continuation 1002807200 · Dec 19, 2001
Continuation PCTUS003267800 · Dec 1, 2000
Continuation In Part PCTUS002332800 · Aug 24, 2000
Continuation In Part PCTUS000434200 · Feb 18, 2000
Continuation In Part 0940329700
Provisional Application 6010603000 · Oct 28, 1998
Related Publication 20030203431A1 · Oct 30, 2003